vs
Side-by-side financial comparison of Axon Enterprise (AXON) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Axon Enterprise is the larger business by last-quarter revenue ($796.7M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 0.3%, a 6.5% gap on every dollar of revenue. On growth, Axon Enterprise posted the faster year-over-year revenue change (38.9% vs -1.7%). Over the past eight quarters, Axon Enterprise's revenue compounded faster (31.5% CAGR vs -0.1%).
Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
AXON vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $796.7M | $493.8M |
| Net Profit | $2.7M | $33.7M |
| Gross Margin | 57.9% | — |
| Operating Margin | -6.3% | 9.9% |
| Net Margin | 0.3% | 6.8% |
| Revenue YoY | 38.9% | -1.7% |
| Net Profit YoY | -98.0% | 10.5% |
| EPS (diluted) | $0.02 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $796.7M | $493.8M | ||
| Q3 25 | $710.6M | $492.9M | ||
| Q2 25 | $668.5M | $468.8M | ||
| Q1 25 | $603.6M | $458.4M | ||
| Q4 24 | $573.4M | $502.4M | ||
| Q3 24 | $544.3M | $511.2M | ||
| Q2 24 | $504.1M | $504.3M | ||
| Q1 24 | $460.7M | $495.1M |
| Q4 25 | $2.7M | $33.7M | ||
| Q3 25 | $-2.2M | $71.7M | ||
| Q2 25 | $36.1M | $39.3M | ||
| Q1 25 | $88.0M | $20.7M | ||
| Q4 24 | $136.0M | $30.5M | ||
| Q3 24 | $67.0M | $19.4M | ||
| Q2 24 | $40.8M | $-153.0M | ||
| Q1 24 | $133.2M | $4.0M |
| Q4 25 | 57.9% | — | ||
| Q3 25 | 60.1% | — | ||
| Q2 25 | 60.4% | — | ||
| Q1 25 | 60.6% | — | ||
| Q4 24 | 60.5% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 60.3% | — | ||
| Q1 24 | 56.4% | — |
| Q4 25 | -6.3% | 9.9% | ||
| Q3 25 | -0.3% | 13.8% | ||
| Q2 25 | -0.2% | 12.8% | ||
| Q1 25 | -1.5% | 7.0% | ||
| Q4 24 | -2.6% | 7.8% | ||
| Q3 24 | 4.4% | 6.6% | ||
| Q2 24 | 6.5% | -31.3% | ||
| Q1 24 | 3.5% | 3.2% |
| Q4 25 | 0.3% | 6.8% | ||
| Q3 25 | -0.3% | 14.5% | ||
| Q2 25 | 5.4% | 8.4% | ||
| Q1 25 | 14.6% | 4.5% | ||
| Q4 24 | 23.7% | 6.1% | ||
| Q3 24 | 12.3% | 3.8% | ||
| Q2 24 | 8.1% | -30.3% | ||
| Q1 24 | 28.9% | 0.8% |
| Q4 25 | $0.02 | $0.40 | ||
| Q3 25 | $-0.03 | $0.84 | ||
| Q2 25 | $0.44 | $0.46 | ||
| Q1 25 | $1.08 | $0.24 | ||
| Q4 24 | $1.68 | $0.37 | ||
| Q3 24 | $0.86 | $0.23 | ||
| Q2 24 | $0.53 | $-1.84 | ||
| Q1 24 | $1.73 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $375.2M |
| Total DebtLower is stronger | $1.8B | $570.5M |
| Stockholders' EquityBook value | $3.2B | $865.9M |
| Total Assets | $7.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.56× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $375.2M | ||
| Q3 25 | $2.4B | $340.1M | ||
| Q2 25 | $2.1B | $224.7M | ||
| Q1 25 | $2.2B | $99.0M | ||
| Q4 24 | $788.1M | $229.9M | ||
| Q3 24 | $1.0B | $103.8M | ||
| Q2 24 | $968.9M | $19.4M | ||
| Q1 24 | $964.1M | $8.0M |
| Q4 25 | $1.8B | $570.5M | ||
| Q3 25 | $2.0B | $577.2M | ||
| Q2 25 | $2.0B | $583.9M | ||
| Q1 25 | $2.0B | $590.5M | ||
| Q4 24 | $680.3M | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.2B | $865.9M | ||
| Q3 25 | $3.0B | $890.7M | ||
| Q2 25 | $2.7B | $833.8M | ||
| Q1 25 | $2.6B | $789.2M | ||
| Q4 24 | $2.3B | $764.9M | ||
| Q3 24 | $2.1B | $732.5M | ||
| Q2 24 | $1.9B | $706.5M | ||
| Q1 24 | $1.8B | $856.2M |
| Q4 25 | $7.0B | $2.2B | ||
| Q3 25 | $6.7B | $2.2B | ||
| Q2 25 | $6.2B | $2.1B | ||
| Q1 25 | $6.1B | $2.0B | ||
| Q4 24 | $4.5B | $2.2B | ||
| Q3 24 | $4.0B | $2.1B | ||
| Q2 24 | $3.7B | $2.0B | ||
| Q1 24 | $3.6B | $2.2B |
| Q4 25 | 0.56× | 0.66× | ||
| Q3 25 | 0.66× | 0.65× | ||
| Q2 25 | 0.73× | 0.70× | ||
| Q1 25 | 0.79× | 0.75× | ||
| Q4 24 | 0.29× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $217.2M | $114.1M |
| Free Cash FlowOCF − Capex | $155.4M | — |
| FCF MarginFCF / Revenue | 19.5% | — |
| Capex IntensityCapex / Revenue | 7.8% | — |
| Cash ConversionOCF / Net Profit | 79.14× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $75.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.2M | $114.1M | ||
| Q3 25 | $60.0M | $137.3M | ||
| Q2 25 | $-91.7M | $137.2M | ||
| Q1 25 | $25.8M | $-117.5M | ||
| Q4 24 | $250.2M | $133.0M | ||
| Q3 24 | $91.3M | $91.8M | ||
| Q2 24 | $82.8M | $107.0M | ||
| Q1 24 | $-15.9M | $-125.2M |
| Q4 25 | $155.4M | — | ||
| Q3 25 | $33.4M | — | ||
| Q2 25 | $-114.7M | — | ||
| Q1 25 | $932.0K | — | ||
| Q4 24 | $225.4M | — | ||
| Q3 24 | $64.8M | — | ||
| Q2 24 | $71.4M | — | ||
| Q1 24 | $-32.1M | — |
| Q4 25 | 19.5% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | -17.2% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 39.3% | — | ||
| Q3 24 | 11.9% | — | ||
| Q2 24 | 14.2% | — | ||
| Q1 24 | -7.0% | — |
| Q4 25 | 7.8% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 3.5% | — |
| Q4 25 | 79.14× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | -2.54× | 3.49× | ||
| Q1 25 | 0.29× | -5.66× | ||
| Q4 24 | 1.84× | 4.36× | ||
| Q3 24 | 1.36× | 4.72× | ||
| Q2 24 | 2.03× | — | ||
| Q1 24 | -0.12× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXON
| Software And Sensors Segment | $342.5M | 43% |
| TASER Devices Professional | $264.2M | 33% |
| Personal Sensors | $109.1M | 14% |
| Platform Solutions | $80.9M | 10% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
